AAPL343.37+3.29 (+0.97%) ▲|ABBV265.81+2.61 (+0.99%) ▲|ABT108.74+1.47 (+1.37%) ▲|ACN174.95+10.29 (+6.25%) ▲|ADBE264.54+15.36 (+6.16%) ▲|AMAT450.72-25.74 (-5.40%) ▼|AMD438.41-16.21 (-3.57%) ▼|AMGN389.84-3.26 (-0.83%) ▼|AMT173.52+2.02 (+1.18%) ▲|AMZN231.30+0.44 (+0.19%) ▲|AVGO377.12-3.80 (-1.00%) ▼|AXP333.13-3.51 (-1.04%) ▼|BA215.89-5.68 (-2.56%) ▼|BAC61.60-1.03 (-1.64%) ▼|BKNG204.03+4.72 (+2.37%) ▲|BLK1,098.17+0.62 (+0.06%) ▲|BMY63.67+0.07 (+0.10%) ▲|BNY153.55-2.95 (-1.88%) ▼|BRK-B510.63-1.75 (-0.34%) ▼|C127.65-4.83 (-3.64%) ▼|CAT781.26-59.60 (-7.09%) ▼|CL93.31+0.58 (+0.62%) ▲|CMCSA24.85+0.66 (+2.71%) ▲|COF210.38-2.03 (-0.96%) ▼|COP118.22+4.12 (+3.61%) ▲|COST974.80+8.22 (+0.85%) ▲|CRM189.06+7.56 (+4.17%) ▲|CSCO114.03-1.56 (-1.35%) ▼|CVS106.54-2.80 (-2.56%) ▼|CVX191.72+4.14 (+2.21%) ▲|DE614.72-25.13 (-3.93%) ▼|DHR198.11-0.94 (-0.47%) ▼|DIS98.89+0.00 (+0.00%) ▲|DUK129.38+0.14 (+0.11%) ▲|EMR146.87-4.94 (-3.25%) ▼|FDX309.34-3.31 (-1.06%) ▼|GD388.52-4.67 (-1.19%) ▼|GE353.79-9.80 (-2.70%) ▼|GEV906.96-36.42 (-3.86%) ▼|GILD134.43+0.11 (+0.08%) ▲|GM91.16+0.86 (+0.95%) ▲|GOOG338.98+6.38 (+1.92%) ▲|GOOGL339.83+6.12 (+1.83%) ▲|GS991.09-42.25 (-4.09%) ▼|HD340.69-3.78 (-1.10%) ▼|HON243.80-3.26 (-1.32%) ▼|IBM228.83+1.28 (+0.56%) ▲|INTC83.98-2.32 (-2.69%) ▼|INTU335.65+22.66 (+7.24%) ▲|ISRG354.36-7.44 (-2.06%) ▼|JNJ266.31-0.42 (-0.16%) ▼|JPM347.40-9.92 (-2.77%) ▼|KO89.12+0.85 (+0.96%) ▲|LIN511.51+0.33 (+0.06%) ▲|LLY1,218.56-2.11 (-0.17%) ▼|LMT576.19-5.12 (-0.88%) ▼|LOW217.71-0.53 (-0.24%) ▼|LRCX258.45-11.16 (-4.14%) ▼|MA566.34+3.59 (+0.64%) ▲|MCD272.04-0.99 (-0.36%) ▼|MDLZ65.20+2.72 (+4.35%) ▲|MDT87.62+0.74 (+0.85%) ▲|META593.40-0.02 (0.00%) ▼|MMM179.43-3.05 (-1.67%) ▼|MO75.17+0.35 (+0.47%) ▲|MRK131.08-0.74 (-0.56%) ▼|MS204.67-6.91 (-3.27%) ▼|MSFT398.10+4.75 (+1.21%) ▲|MU763.76-56.78 (-6.92%) ▼|NEE88.83-0.45 (-0.50%) ▼|NFLX73.58+1.19 (+1.64%) ▲|NKE43.17+0.12 (+0.27%) ▲|NOW116.38+5.76 (+5.21%) ▲|NVDA192.84-4.17 (-2.12%) ▼|ORCL119.28-0.69 (-0.57%) ▼|PEP144.34+1.48 (+1.04%) ▲|PFE25.20-0.06 (-0.22%) ▼|PG145.07-3.82 (-2.56%) ▼|PLTR125.19+1.66 (+1.34%) ▲|PM199.72-0.46 (-0.23%) ▼|QCOM160.70-2.19 (-1.34%) ▼|RTX218.92+0.34 (+0.16%) ▲|SBUX104.02+0.92 (+0.89%) ▲|SCHW105.62-0.35 (-0.33%) ▼|SO96.21-0.57 (-0.59%) ▼|SPG237.38+0.68 (+0.29%) ▲|T24.33-0.34 (-1.36%) ▼|TMO571.53-4.88 (-0.85%) ▼|TMUS182.00-0.39 (-0.21%) ▼|TSLA302.43-5.01 (-1.63%) ▼|TXN275.59-1.49 (-0.54%) ▼|UBER71.36+0.62 (+0.88%) ▲|UNH421.63-7.16 (-1.67%) ▼|UNP291.27-3.18 (-1.08%) ▼|UPS104.26-1.28 (-1.21%) ▼|USB63.17-1.26 (-1.96%) ▼|V368.81+2.22 (+0.61%) ▲|VZ48.40+0.21 (+0.43%) ▲|WFC84.44-2.43 (-2.80%) ▼|WMT114.08+0.98 (+0.87%) ▲|XOM156.55+3.51 (+2.29%) ▲|AAPL343.37+3.29 (+0.97%) ▲|ABBV265.81+2.61 (+0.99%) ▲|ABT108.74+1.47 (+1.37%) ▲|ACN174.95+10.29 (+6.25%) ▲|ADBE264.54+15.36 (+6.16%) ▲|AMAT450.72-25.74 (-5.40%) ▼|AMD438.41-16.21 (-3.57%) ▼|AMGN389.84-3.26 (-0.83%) ▼|AMT173.52+2.02 (+1.18%) ▲|AMZN231.30+0.44 (+0.19%) ▲|AVGO377.12-3.80 (-1.00%) ▼|AXP333.13-3.51 (-1.04%) ▼|BA215.89-5.68 (-2.56%) ▼|BAC61.60-1.03 (-1.64%) ▼|BKNG204.03+4.72 (+2.37%) ▲|BLK1,098.17+0.62 (+0.06%) ▲|BMY63.67+0.07 (+0.10%) ▲|BNY153.55-2.95 (-1.88%) ▼|BRK-B510.63-1.75 (-0.34%) ▼|C127.65-4.83 (-3.64%) ▼|CAT781.26-59.60 (-7.09%) ▼|CL93.31+0.58 (+0.62%) ▲|CMCSA24.85+0.66 (+2.71%) ▲|COF210.38-2.03 (-0.96%) ▼|COP118.22+4.12 (+3.61%) ▲|COST974.80+8.22 (+0.85%) ▲|CRM189.06+7.56 (+4.17%) ▲|CSCO114.03-1.56 (-1.35%) ▼|CVS106.54-2.80 (-2.56%) ▼|CVX191.72+4.14 (+2.21%) ▲|DE614.72-25.13 (-3.93%) ▼|DHR198.11-0.94 (-0.47%) ▼|DIS98.89+0.00 (+0.00%) ▲|DUK129.38+0.14 (+0.11%) ▲|EMR146.87-4.94 (-3.25%) ▼|FDX309.34-3.31 (-1.06%) ▼|GD388.52-4.67 (-1.19%) ▼|GE353.79-9.80 (-2.70%) ▼|GEV906.96-36.42 (-3.86%) ▼|GILD134.43+0.11 (+0.08%) ▲|GM91.16+0.86 (+0.95%) ▲|GOOG338.98+6.38 (+1.92%) ▲|GOOGL339.83+6.12 (+1.83%) ▲|GS991.09-42.25 (-4.09%) ▼|HD340.69-3.78 (-1.10%) ▼|HON243.80-3.26 (-1.32%) ▼|IBM228.83+1.28 (+0.56%) ▲|INTC83.98-2.32 (-2.69%) ▼|INTU335.65+22.66 (+7.24%) ▲|ISRG354.36-7.44 (-2.06%) ▼|JNJ266.31-0.42 (-0.16%) ▼|JPM347.40-9.92 (-2.77%) ▼|KO89.12+0.85 (+0.96%) ▲|LIN511.51+0.33 (+0.06%) ▲|LLY1,218.56-2.11 (-0.17%) ▼|LMT576.19-5.12 (-0.88%) ▼|LOW217.71-0.53 (-0.24%) ▼|LRCX258.45-11.16 (-4.14%) ▼|MA566.34+3.59 (+0.64%) ▲|MCD272.04-0.99 (-0.36%) ▼|MDLZ65.20+2.72 (+4.35%) ▲|MDT87.62+0.74 (+0.85%) ▲|META593.40-0.02 (0.00%) ▼|MMM179.43-3.05 (-1.67%) ▼|MO75.17+0.35 (+0.47%) ▲|MRK131.08-0.74 (-0.56%) ▼|MS204.67-6.91 (-3.27%) ▼|MSFT398.10+4.75 (+1.21%) ▲|MU763.76-56.78 (-6.92%) ▼|NEE88.83-0.45 (-0.50%) ▼|NFLX73.58+1.19 (+1.64%) ▲|NKE43.17+0.12 (+0.27%) ▲|NOW116.38+5.76 (+5.21%) ▲|NVDA192.84-4.17 (-2.12%) ▼|ORCL119.28-0.69 (-0.57%) ▼|PEP144.34+1.48 (+1.04%) ▲|PFE25.20-0.06 (-0.22%) ▼|PG145.07-3.82 (-2.56%) ▼|PLTR125.19+1.66 (+1.34%) ▲|PM199.72-0.46 (-0.23%) ▼|QCOM160.70-2.19 (-1.34%) ▼|RTX218.92+0.34 (+0.16%) ▲|SBUX104.02+0.92 (+0.89%) ▲|SCHW105.62-0.35 (-0.33%) ▼|SO96.21-0.57 (-0.59%) ▼|SPG237.38+0.68 (+0.29%) ▲|T24.33-0.34 (-1.36%) ▼|TMO571.53-4.88 (-0.85%) ▼|TMUS182.00-0.39 (-0.21%) ▼|TSLA302.43-5.01 (-1.63%) ▼|TXN275.59-1.49 (-0.54%) ▼|UBER71.36+0.62 (+0.88%) ▲|UNH421.63-7.16 (-1.67%) ▼|UNP291.27-3.18 (-1.08%) ▼|UPS104.26-1.28 (-1.21%) ▼|USB63.17-1.26 (-1.96%) ▼|V368.81+2.22 (+0.61%) ▲|VZ48.40+0.21 (+0.43%) ▲|WFC84.44-2.43 (-2.80%) ▼|WMT114.08+0.98 (+0.87%) ▲|XOM156.55+3.51 (+2.29%) ▲|
26.8 C
New York
Wednesday, July 29, 2026
Press ReleasesHealth CareEAACI 呼籲推動「零願景」未來,致力消除過敏症與哮喘帶來的健康負擔

EAACI 呼籲推動「零願景」未來,致力消除過敏症與哮喘帶來的健康負擔

蘇黎世, June 13, 2026 (GLOBE NEWSWIRE) — 隨著過敏疾病持續對全球數以億計人口帶來影響,亦為醫療系統增添壓力,European Academy of Allergy and Clinical Immunology (EAACI) 呼籲在全球健康領域樹立全新目標:實現「零願景」的未來,消除過敏症與哮喘病帶來的健康負擔。

這個願景將成為 2026 年 EAACI 年會上的核心主題。年會將於 2026 年 6 月 12 日至 15 日在土耳其伊斯坦堡舉行,屆時將有數以千計的臨床醫生、研究人員和醫療專才聚首一堂,共同探討最新的科學進展,以及過敏症與哮喘病護理的方向。

EAACI 認為,與其將過敏及呼吸道疾病視為無可避免且日益嚴峻的公共衛生考驗,倒不如透過科學創新、預防策略與協調一致的政策行動,顯著減低這些疾病對個人、家庭及社會的影響。

EAACI 主席 María Torres 表示:「『零願景』體現我們衝出疾病管理的框架,轉向疾病預防與減輕負擔的決心。基於當前所見的科學進展,我們有足夠理由追求更大的目標。透過研究、臨床實踐和公共衛生領域的合作,我們可以努力創造未來,讓過敏症與哮喘不再令數以百萬人的生活受到限制。」

這次年會將展示免疫療法、環境和遺傳因素、數碼健康技術、精準醫療和預防方法等領域的新興研究與臨床進展。討論亦將針對健康公平議題,並強調確保全球患者都可獲得更佳的過敏症與哮喘病護理。

過敏疾病是全球最常見的慢性病之一,在不少地區的普遍程度持續攀升。這些疾病不僅為醫療保健帶來負擔,亦影響到教育、生產力、生活質素和心理健康。在此環境下,EAACI 的「零願景」倡議旨在鼓勵從長遠角度思考,當科學探索與有效執行及政策支援相輔相成時,到底可以實現哪些可能性。

EAACI 年會副主席 André Moreira 表示 :「『零願景』的概念挑戰我們要以不同的角度思考, 鼓勵過敏症社群不僅要著眼於疾病的治療,亦要從預防方面著手,減低其影響,為未來世代創造更健康的環境。」

伊斯坦堡位處歐亞要衝,為國際合作和知識交流提供理想環境。年會預計將雲集來自全球各地的專家,共同加速推動發展,力求大幅降低未來因過敏症與哮喘病導致的健康負擔。

關於 EAACI

European Academy of Allergy and Clinical Immunology (EAACI) 是致力在過敏症及免疫學領域追求卓越的頂尖專業機構。EAACI 透過研究、教育、宣傳及促進優質的患者護理,致力改善過敏疾病患者的健康。

媒體聯絡方式:communications@eaaci.org

Source: https://www.globenewswire.com/news-release/2026/06/13/3311403/0/zh-hant/EAACI-%E5%91%BC%E7%B1%B2%E6%8E%A8%E5%8B%95-%E9%9B%B6%E9%A1%98%E6%99%AF-%E6%9C%AA%E4%BE%86-%E8%87%B4%E5%8A%9B%E6%B6%88%E9%99%A4%E9%81%8E%E6%95%8F%E7%97%87%E8%88%87%E5%93%AE%E5%96%98%E5%B8%B6%E4%BE%86%E7%9A%84%E5%81%A5%E5%BA%B7%E8%B2%A0%E6%93%94.html

Recent News